PGAM
CYTH

Princeton Global Asset Management’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

Princeton Global Asset Management’s Portfolio CYTH Stock Details CYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,466
Closed -$2.73K – 694
2024
Q3 		$2.73K Sell
3,466
-300
-8% -$300 ﹤0.01% 593
2024
Q2 		$4.78K Hold
3,766
– – ﹤0.01% 534
2024
Q1 		$5.24K Buy
3,766
+3,466
+1,155% +$5.73K ﹤0.01% 490
2023
Q4 		$477 Hold
300
– – ﹤0.01% 622
2023
Q3 		$426 Hold
300
– – ﹤0.01% 563
2023
Q2 		$477 Hold
300
– – ﹤0.01% 558
2023
Q1 		$252 Hold
300
– – ﹤0.01% 575
2022
Q4 		$0 Buy
+300
New +$496 ﹤0.01% 592

Other funds holding CYTH

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $45.5B AUM 21.01% 1-Year Est. Return